ASK REDCHAT ANYTHING ABOUT KINIKSA PHARMACEUTICALS, LTD.
Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA)
Listen to this Section
$48.65
-0.5810
(
-1.18% )
124.0K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Abiprubart (KPL-404) (CD40)DetailsAutoimmune disease, Sjögren-Larsson Syndrome |
Phase 2b |
| Abiprubart (KPL-404) (CD40)DetailsAutoimmune disease, Rheumatoid arthritis |
Phase 2 |
| Mavrilimumab (GM-CSFRa)DetailsInflammatory disease, Giant cell arteritis |
Failed |
| Mavrilimumab (GM-CSFRa)DetailsCOVID-19, Pneumonia |
Failed |
Market Data
|
| Open |
$48.65 |
| Previous Close |
$49.23 |
| Volume |
124.0K |
| Market Cap |
$3.68B |
| Day Range |
$48.50 - $50.89 |
| 52 Week Range |
$26.27 - $59.87 |
| Shares Outstanding |
76.94M |
| Change % |
-1.18% |
| Net Change |
▼ -0.5810 |
| Insider Ownership |
-0.02% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| IPO Year | 2018 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-449,791.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-01-04 |
Sale |
-16670.00 |
Megna Michael R |
| 2024-01-04 |
Sale |
-12000.00 |
Ragosa Mark |
| 2023-12-21 |
Sale |
-9316.00 |
Megna Michael R |
| 2023-12-11 |
Sale |
-28600.00 |
Paolini John F. |
| 2023-11-07 |
Sale |
-2777.00 |
Levy Richard S |
| 2023-10-06 |
Sale |
-175.00 |
Megna Michael R |
| 2023-09-06 |
Sale |
-292.00 |
Moat Ross |
| 2023-09-06 |
Sale |
-581.00 |
Megna Michael R |
| 2023-09-06 |
Sale |
-9992.00 |
Patel Sanj K |
| 2023-09-06 |
Sale |
-2695.00 |
Ragosa Mark |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 4 |
Insider transactions |
2 |
Nov 04, 2025 |
| 4 |
Insider transactions |
2 |
Oct 30, 2025 |
| 8-k |
8K-related |
14 |
Oct 28, 2025 |
| 10-q |
Quarterly Reports |
77 |
Oct 28, 2025 |
| 4 |
Insider transactions |
2 |
Oct 22, 2025 |
| 4 |
Insider transactions |
1 |
Oct 22, 2025 |
| 4 |
Insider transactions |
2 |
Oct 16, 2025 |
| 4 |
Insider transactions |
2 |
Oct 08, 2025 |
| 4 |
Insider transactions |
1 |
Oct 01, 2025 |
| 4 |
Insider transactions |
1 |
Sep 17, 2025 |